Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Kidney cancer, Renal cell cancer
Closed
Phase 4
This study is looking to see if pazopanib (Votrient) helps people with advanced kidney cancer.
Pazopanib is a type of biological therapy. It works by blocking signals that tell cancer cells to grow. It is one of the drugs that doctors can use to treat advanced kidney cancer.
The researchers want to find out more information about how well pazopanib works and how it affects .
Taking part in this study will not affect your treatment, as your doctor will be prescribing this drug for you whether or not you join the study. But the information they gather from the study may help doctors learn more about pazopanib.
Recruitment start: 1 August 2012
Recruitment end: 31 December 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Robert Hawkins
GlaxoSmithKline (GSK)
NIHR Clinical Research Network: Cancer
Last reviewed: 31 Dec 2014
CRUK internal database number: 9725
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
